09th November 2024

The General Manager, The Manager,

Department of Corporate Services Listing Department
Bombay Stock Exchange Ltd (BSE) National Stock Exchange of India Limited,
Phiroze Jheejheebhoy Towers, Exchange Plaza, 5th Floor,
Dalal Street, Plot No.C/1, 'G' Block,
Mumbai - 400 001. Bandra - Kurla Complex,
Scrip Code - 543308 Mumbai - 400 051.
ISIN: INE967H01025 Symbol - KIMS
ISIN: INE967H01025

Dear Sir,

Sub: Investor Presentation

Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and
Disclosure Requirements) Regulations, 2015 please find enclosed herewith the Investor Presentation on
unaudited (Standalone & Consolidated) financial results of the Company for the 02nd quarter and half-
year ended 30th September 2024.

The said presentation is being uploaded on the website of the Company i.e.,
https://www.kimshospitals.com/investors/Disclosures under Regulation 46 of SEBI (LODR)
Regulations, 2015/Analysts Calls schedule, PPT & Transcripts/PPT's.

We request you to take this on record.

Thanking you,
Yours truly,
For Krishna Institute of Medical Sciences Limited

Digitally signed by MANTHA

MANTHA SHANKER UMA

SHANKER UMA Date: 2024.11.09 16:30:42

+05'30'

Umashankar Mantha
Company Secretary & Compliance Officer

Enclosed: As above
Krishna Institute of Medical Sciences Limited
D.No.: 1-8-31/1, Minister Road, Secunderabad - 500 003, Telangana, India
Phone: +91 40 4488 5000/4488 5184 | Fax: +91-40-27840980 | kimshospitals.com
CIN: L55101TG1973PLC040558
 Q2 FY25 UPDATE

Private & Confidential

 Driven by a Vision

Affordable Quality Care

VISION: Best-in-Class Facilities
Patient Centric Systems & Processes

S
To be the most preferred

NT
healthcare services brand by

TIE
providing affordable care and best

PA
clinical outcomes to patients. Clinical Outcome Driven Excellence
And to be the best place to work RS
CTO Latest Medical Technology
for doctors and employees. D O
Strong Academics & Research Oriented
OUR MISSION: Most
Provide affordable quality care to Preferred
our patients with patient-centric Healthcare
Provider EMPLO
YEES Enriching Atmosphere
systems and processes.
Collaborative Culture
Enable clinical outcome-driven
excellence by engaging modern
Growth Driven Career Approach
medical technology.

IN
VE
Provide a strong impetus for

ST
doctors to pursue academics and
OR
Transparent Governance

S
medical research.
Strong Operational Performance
Consistent Growth

2
Private & Confidential
 Multi Specialty Care
Brain Eyes Bones and Spine Radiology
• Neurology • Ophthalmology • Orthopedics • Imaging
• Neurosurgery Gastro Intestinal Tract • Arthroscopic Surgery • Interventional Radiology
• Psychiatry • Medical Gastroenterology • Spine Surgery Lab Services
• Neuro Rehabilitation • Surgical Gastroenterology • Ortho Rehabilitation • Pathology
Heart • Hepatobiliary Pancreatic Surgery Skin • Microbiology
• Cardiology • Liver Transplant • Dermatology • Biochemistry
• Cardiac Surgery • Bariatric Surgery • Cosmetology • Molecular Biology
• Vascular Surgery Genito Urinary Tract • Plastic and Reconstructive Surgery • Clinical Hematology
• Heart Transplant • Nephrology Orthodontics Critical Care Services
• Cardio Rehabilitation • Urology • Maxillo Facial Surgery • ICU
Lung • Andrology Anaesthesia • CTICU
• Pulmonology • Renal Transplant • OT Anaesthesia • SICU
• Interventional Pulmonology • Gynecology • Day care Anaesthesia • NICU
• Thoracic surgery • Urogynecology • Pain Medicine • PICU
• Lung Transplant • IVF and ART • Neuro ICU
General Specialities
ENT • Fetal Medicine • ECMO ICU
• Internal Medicine
• Ear • Obstetrics • Post Transplant ICU
• General Surgery
• Nose Oncology • Diabetology & Endocrinology Hospital Infection Control
• Throat • Medical Surgical and Radiation • Clinical Infectious Diseases
Pediatrics
• Head and Neck Surgery • BMT and Hematology
• Pediatrics & Pediatric Sub Specialities
• Neonatology
3
Private & Confidential
 KIMS at a Glance
Telangana
Secunderabad (1000)

Maharashtra Begumpet (290)

Nagpur (334) Kondapur (200) + 500 beds under construction

Nashik (325) Gachibowli (237)

Thane (300) - Under Construction

Karnataka Andhra Pradesh

Bengaluru Vizag (KIMS ICON: 434)
Soulspace (450) - Under Construction Vizag (KIMS Hospitals: 300 - Formerly QNRI)
PES (300) - Under Construction
Srikakulam (200) + 120 beds under construction
Rajahmundry (195)
Ongole (350) + 50 beds under construction

Kerala Kurnool (200)

Nellore (250)
Kannur (200)
Anantapur (250) + 250 beds under construction
Guntur (200)
No. in ( ) Indicates no. of Beds
Map not to scale 4
Private & Confidential
 Dr. B. Bhaskar Rao - Visionary Behind KIMS
Chairman & Managing Director

A legend in CT Surgery, Dr. Bollineni Bhaskar Rao {MBBS, MS, DNB (CT Surgery)} is one of the very few Cardio-
Thoracic Surgeons in the country, who performed over 30000 surgeries in his career spanning over more than 25
years.

Well known in the medical fraternity for his passion towards his profession, Dr. Rao started his entrepreneurial journey
at “Mahavir Cardio Vascular Centre” in Hyderabad with 50 beds and performed heart surgeries at an unimaginable
low cost of just Rs. 45,000 only. Dr. Rao never turned away any patient from the hospital for want of money.

The brand “Krishna Institute of Medical Sciences”, under Dr. B. Bhaskar Rao’s aegis began its journey in 2004 with
a 300 bed hospital on par with the then established hospitals of Hyderabad in professional excellence, the state of
art technology and infrastructure facilities.

Today KIMS is spread across Telangana, Andhra Pradesh, Maharashtra, Karnataka (Upcoming) and Kerala.

Dr. Bhaskar Rao was instrumental in formulating Rajiv Gandhi Aarogyasri scheme, first time launched in Andhra
Pradesh in 2007 for providing health care to the poorest of the poor.

This prestigious scheme has won him accolades from all quarters of the country and the world. He was the chief
architect of Aarogyashri scheme for both creating it and implementing it successfully.

This well formulated scheme has become so popular that the other States in India have emulated it time and again.

5
Private & Confidential
 Dr. Abhinay Bollineni
Chief Executive Officer

Dr. Abhinay Bollineni joined KIMS Hospitals in 2013 and spent the next couple of years in Hospital Operations
before taking charge of Strategy & Marketing for the Group in 2015. He was appointed as the CEO in 2019.

Dr. B. Abhinay completed MBBS from the Deccan Medical College, Hyderabad, in 2010. He was the
lone qualified medical practitioner from India to be selected by the office of Hillary Clinton in 2011, where
he participated in the ‘International Visitor Leadership Program on Oncology: Research, Prevention and
Treatment’ held by the US Department of State

He was named in Business World’s “BW 40 Under 40” list in 2019.

Under his stewardship, KIMS Hospitals got successfully listed on the Stock Exchanges in India in 2021.

Dr. Abhinay is passionate about using technology to enhance patient experience and clinical care. Towards
this, he has spearheaded vital initiatives such as Financial counseling tool which uses AI to help patients
with surgery costings among many others

6
Private & Confidential
 Board of Directors

Dr. Bhaskara Rao Bollineni Dr. Abhinay Bollineni Mrs. Anitha Dandamudi Mr. Saumen Chakraborty
Chairman & Managing Director Chief Executive Officer Whole-time Director Independent Director,
Chairman (Audit Committee)

Mr. Adwik Bollineni Mr. Venkata Ramudu Jasthi Mrs. Y. Prameela Rani Mr. Ratna Kishore Kaza
Non-Executive & Independent Director Independent Director Independent Director
Non-Independent Director Chairman (Stakeholders’ Chairman (Nomination &
Relationship Committee) Remuneration Committee)

7
Private & Confidential
 Organizational Announcement - 1/5

We are glad to announce that Dr. Nitish Shetty joins as CEO for KIMS Bengaluru Cluster.

Dr. Nitish joins us with 24 years of experience in the health care services and hospital administration.
He worked with some well-known healthcare companies like Aster DM Health care,BGS Global
Hospital, NH Dental Chain and Narayana Hrudayalaya Hospitals. His areas of expertise includes human
resource management functions, business operations, developing procedures and service standards
for business excellence. Dr.Nitish academic background includes an MD in Hospital Administration
from Kasturba Medical College, Manipal, Karnataka , Senior Registrar in Department of Medicine from
Dr.Ambedkar Medical college ,Bangalore, Senior House surgeon from Karnataka Medical College,
Hubli and M.B.B.S from M.R Medical College, Gulbarga Karnataka. He also Completed Health care
Dr. Nitish Shetty executive training programme at Harvard University Cambridge.
CEO
KIMS Bengaluru Cluster Dr. Nitish will be based at Bengaluru as Managing Director for Bengaluru Cluster. Prior to joining us,
he was associated with Aster DM Healthcare India as group CEO.

8
Private & Confidential
 Organizational Announcement - 2/5

We are happy to announce that Mr. Farhaan Yaseen joins us as CEO for KIMS Kerala Cluster.
He will be a part of our Leadership team and will be based out of Kerala. Mr. Farhaan joins us
with over twenty years of experience in healthcare.

He initially started as Marketing Head in Malabar hospitals Kozhikode and later became CEO in
the same hospital . He was functioning as Kerala Lead in Kerala Private Hospital Association
during that time. After that, he joined as CEO of Aster Mims Kannur and then became CEO of
Aster North Kerala cluster of Hospitals and regional Director of entire Kerala Hospitals. He was
then elevated as Vice President of Aster Kerala Hospitals and Aster India retail network.
Mr. Farhaan Yaseen
CEO
KIMS Kerala Cluster

9
Private & Confidential
 Organizational Announcement - 3/5

We are happy to announce that Mr. Arjun Vijaya Kumar joins us in our ambitious growth journey.

Mr. Arjun Vijayakumar, Chartered Accountant by profession has 16 years of post qualification
experience. His current role is Head - Finance and Account functions for the Kerala cluster. He
will support our foray in the region. Prior to joining KIMS, he was associated with Aster, Ahalia
and Deloitte.

Mr. Arjun Vijaya Kumar

Head - Finance and Account
Kerala Cluster of KIMS

10
Private & Confidential
 Organizational Announcement - 4/5

We are happy to announce that Surg. Capt. Dr. B. Vijaya Kumar (Retd) joins KIMS as an
Executive Director, focusing on the Vizag Cluster.
In his last role while with the Indian Navy, he was designated as Director & Captain (Medical
Services) Equipment & Stores/Foreign Cooperation, Integrated Headquarters of Ministry of
Defence (Navy), Office of Director General Medical Services (Navy), Naval Headquarters, New
Delhi. Dr. Vijaya has led medical operations in difficult circumstances and has exemplified
medical leadership by spearheading initiatives in patient care, medical operations, and healthcare
technology integration, resulting in improved patient outcomes, streamlined processes, and
enhanced healthcare delivery standards. Among his various responsibilities, he has actively
participated in various relief and rescue operations, conducted liaison work with multiple
stakeholder groups, managed recruitment, counselled service personnel and led projects of
Surg. Capt. diverse nature.
Dr. B. Vijaya Kumar (Retd)
Executive Director,
KIMS Vizag Cluster

11
Private & Confidential
 Organizational Announcement - 5/5

Dr. Charan joins us with close to nine years of experience in the Indian Healthcare sector. He
is experienced in the areas of Hospital Operations, Manpower Management and quality Clinical
services .
He worked with some well-known Healthcare companies like Yashoda Hospitals and Manipal
Hospitals. His areas of expertise includes coordination for NABH accreditations, Operations
and Business management.
He has post graduate degrees of MD in Hospital Administration(Kasturba Medical College,
Manipal, Karnataka) , DNB in Health and Hospital Administration (National Board of Examinations,
New Delhi)Diploma in Medical law and ethics(National Law School Of India University, Bangalore)
and M.B.B.S ( Katuri Medical College ,Guntur).
Dr. Charan Tej Koyi His last assignment before joining us was with Yashoda Hospitals as Associate Vice President
VP - Clinical Talent Acquisition
AP Cluster
- Medical services.

12
Private & Confidential
 Shareholding Pattern - As on 30 September, 2024 th

Retail & Others,

Retail Pre IPO, 3.8%
7.1%

Promoter & Promoter Share Holder No of Shares Share Holding % Category

Group, 38.8% Promoter 15,52,56,520 38.8%

Sbi Mf 2,87,02,805 7.2% DII

Hdfc Mf 1,83,76,584 4.6% DII
FII, 17.5% Axis Mf 1,76,99,810 4.4% DII
Nomura 1,19,26,860 3.0% FII
SBI Insurance 1,15,01,200 2.9% DII
Vanguard Equity Funds 94,88,632 2.4% FII
Kotak Fund 94,06,220 2.4% DII
Lilac Investments Limited 78,50,000 2.0% FII
Amansa Holdings Private Limited 77,04,880 1.9% FII
Icici Mf 70,06,845 1.8% DII

DII, 32.8%

13
Private & Confidential
 Modern Medical Technology

4-Arm HD da Vinci MrGFUS Focussed Other Key Equipments

Robotic Surgical Ultrasound
System Revolutionary Knifeless Brain • O-Arm Scanner
Facilitates complex procedure for treating tremors. • Spy Glass
surgeries that are virtually Proven to reduce Tremors
scarless • Fibroscan
severity and improve quality of
life for Parkinson’s & Essential • Novalis Tx Linear
Tremors Patients. Accelerator
• Cuvis Ortho Robo
Mako Robotic for Knee ESWL Dornier • EBUS
Replacement It offers powerful imaging, • STEALTH STATION
Produces minimal blood loss maximized energy, and S8
and a smaller scar. Helps enhanced efficiency.
preserve healthy bone and • IMPELLA
It allows for better diagnosis,
soft tissue. Results in less better treatment, and better • EVIS X1 Endoscopy
post-operative pain than patient follow-up at no System
manual techniques. additional radiation risk.

14
Private & Confidential
 Many Firsts...

• First in Asia in to do Trans catheter • India’s first COVID Double Lung • Number 1 in Nephrology treatments in
Tricuspid Valve replacement transplant done in 2020 Andhra Pradesh*
procedure done in 2018 • India’s first Breathing Lung transplant • Number 1 in Neurosurgery & Poly
• Largest Joint replacement program done in 2021 trauma treatments in Andhra Pradesh*
in South Asia. • First hospital in South India to • Number 1 in Cardio related surgeries
• One of the largest neuroscience introduce Da Vinci Robotic System and treatments programs in Andhra
programs for epilepsy among private • The first hospital in Andhra Pradesh Pradesh *
hospitals in the country and Telangana to have been Green OT • Number 1 in Urology (Genito-Urinary)
• Largest ECMO program (18 certified in 2016 surgeries performed in Andhra
machines) in the country. • First hospital in India to perform Arch Pradesh*
• First hospital in Hyderabad to use Repair in Neonates and infants without
an ECMO machine in 2013. TCA
• First hospital in Hyderabad to do a • First Hospital in South India to do
Neonatal ECMO Total Skin Electron Beam Radiation
• First in India to do TOF repair using therapy in 2018
CorMatrix patch for pulmonary valve • Number 1 player in Organ
reconstruction in 2017 transplantation speciality (Heart, Lung,
• First in the country to do Liver and Kidney)*
Robotic spleen preserving distal
pancreatectomy

*As per CRISIL Report 2021

15
Private & Confidential
 Key Accomplishments

NAL ACCRED
ATIO IT
N

AT
ER

ION
INT
QU

Y
ET
LI
AF

A
TY
& PAT I E N T S

Pharmacie De Qualite (PDQ)

American Accreditation Commission Certification Overall PDQ Evaluation ‘Best Patient Friendly Hospital’
Ranked No. 1 Hospital International (AACI) Performance Score - 98% AHPI Health Care Excellence
by Times of India, Hyderabad Accredited Grading - PLATINUM Award (2017)

‘Best Hospital to Work For’ 2nd Best Hospital in 20th National Award for National Quality Excellence
AHPI Global Conclave Hyderabad (2021 & 2022) Excellence in Energy Management Awards 2019 for Best Super
Award (2019) Award 2019 Specialty Hospital in Telangana

2016 2019 2021

Neurology Department at KIMS Sec. Best Super-Specialty 2020 Ranked No.1 in Hyderabad for
KIMS Secunderabad Hospital in Telangana Only Hospital in Telangana Cardiology, Neurosciences,
ranked 3rd in India to get NABH Accredition for Nephrology & Emergency
National Quality Emergency Department
Neurology India General Excellence Awards Times Health Survey
Times of India

16
Private & Confidential
 Consistent Performer over 2 decades
(Rupees in Millions)

25,112 6,232
22,235 5,766

% .1%
: 2 7.1 16,711 : 3 0 5,217
R
CAG GR
CA
11,287

2,412

4,280
773
1,311
317
263 42

2005 2010 2015 2020 2022 2023** 2024 2005 2010 2015 2020 2022*** 2023** 2024
No. of No. of No. of No. of No. of No. of No. of
Hospitals: 1 Hospitals: 3 Hospitals: 5 Hospitals: 9 Hospitals: 12 Hospitals: 12 Hospitals: 12

Total Revenue *EBITDA

1) *EBITDA before IND AS and other income

2) **Revenue and EBITDA are including 7 month performance (Sep'22 - Mar’23) of the newly acquired unit at Nagpur
3) ***FY22 EBITDA includes share of profit from JV (Sunshine)
17
Private & Confidential
 Q2 FY25 Updates

18
Private & Confidential
 Financial & Operational Highlights - 1/2
(Rupees in Cr)

FINANCIAL
HIGHLIGHTS Q2 FY 25 Consolidated
• Gross revenue of INR 782 Cr, a growth of 19.4% on YoY and 12.9% on QoQ basis.
• EBITDA of INR 223 Cr, a growth of 23.8% on YoY and 21.2% on QoQ basis.
• EBITDA margin at 28.5% vs. 27.5% in Q2 FY24 and 26.6% in Q1 FY25.
• EBITDA Margin (excluding Other Income) stands at 28.1% vs. 27.2% in Q2 FY24 and 26.1% in Q1 FY25.
• PAT at INR 121 Cr in Q2 FY25 against INR 101 Cr and INR 95 Cr in Q2 FY24 and Q1 FY25 respectively.
• Consolidated EPS** of INR 3, a growth of 16.7% on YoY and 24.0% on QoQ basis.
• Cash and Cash Equivalents (includes Cash, Bank balance, Deposits with maturity less than 12 months and Investment in Mutual funds) at
INR 90 Cr as on Q2 FY25.
• Consolidated Key Financials figures are as follows (Rs in Cr) :

Consoldiated - FY25 Q2 Results

Particulars
Q2 FY25 Q1 FY25 Q2 FY24 QoQ YoY

Total Income 782.3 693.0 655.4

Less : Other Income 5.0 4.6 2.9
Revenue from Operations 777.3 688.4 652.5 12.9% 19.1%
PBT* 162.2 127.1 138.7 27.6% 16.9%
Add : Interest 19.9 17.9 8.9
Add : Depreciation 41.0 39.0 32.6
Reported EBITDA (Incl. other income) as per Financials 223.1 183.9 180.2 21.3% 23.8%
Less : Other Income 5.0 4.6 2.9
Less : INDAS 3.4 7.4 5.1
EBITDA Pre INDAS & Excl.Other Income 214.7 171.9 172.3 24.9% 24.6%
EBITDA % to Revenue from Operations 27.6% 25.0% 26.4%

*PBT are excluding one time items of - Share of loss of associate of Rs.0.22mn in Q2 FY24
**The equity shares of the Companyof Rs.10/ has been sub-divided into 5 equity shares of Rs.2/- each w.e.f. September 13,2024, accordingly EPS has been restated for all the periods.
19
Private & Confidential
 Financial & Operational Highlights - 2/2

OPERATIONAL
Q2 FY 25 Consolidated
HIGHLIGHTS
• ARPOB grew by 22.9% and degrew by 0.5% on YoY and QoQ basis respectively
• ARPP grew by 9.7% and 0.7% on YoY and QoQ basis respectively
• IP Volume grew by 9.1% and 12.2% on YoY and QoQ basis respectively

FY25 Q2 Results
Particulars
Q2 FY25 Q1 FY25 Q2 FY24 QoQ YoY

IP Volumes 55,741 49,674 51,115 12.2% 9.1%

OP Volumes 4,73,989 4,21,367 4,22,499 12.5% 12.2%
ARPOB (Rs) 38,263 38,458 31,140 -0.5% 22.9%
ARPP(Rs) 1,40,316 1,39,398 1,27,959 0.7% 9.7%

20
Private & Confidential
 Group Operating Performance - 1/2

IP VOLUME (‘000) OP VOLUME (‘000)

7.9% 8.3% 12.2% 9.9% 11.2% 12.5%
191 105 56 1,608 895 474
177 51 1,462 422 421
97 50 805
137 1,014

FY22 FY23 FY24 H1 FY24 H1 FY25 Q2 FY24 Q1 FY25 Q2 FY25 FY22 FY23 FY24 H1 FY24 H1 FY25 Q2 FY24 Q1 FY25 Q2 FY25

OCCUPANCY ARPOB (‘000) (0.5%)

(7.7%) (0.1%) 6.6% 22.1%
58.5% 1.5% 55.2% 57.4% 31.9 38.4 38.5 38.3
49.8% 29.9 31.4
54.0% 49.7% 31.1
52.6% 47.5% 25.3

FY22 FY23 FY24 H1 FY24 H1 FY25 Q2 FY24 Q1 FY25 Q2 FY25 FY22 FY23 FY24 H1 FY24 H1 FY25 Q2 FY24 Q1 FY25 Q2 FY25

1) Nagpur - Started operations from September 2022

21
Private & Confidential
 Group Operating Performance - 2/2
Particulars FY23 FY24 H1 FY24 H1 FY25 Q2 FY24 Q1 FY25 Q2 FY25
Bed Capacity 3,940 3,975 3,975 4,610 3,975 3,975 4,610
Operational Beds 3,468 3,503 3,503 4,038 3,503 3,503 4,038
Census Beds 2,960 2,989 2,989 3,524 2,989 2,989 3,524
Non Census Beds 508 514 514 514 514 514 514
Occupied Beds 2,071 2,148 2,194 2,188 2,283 1,979 2,292
Occupancy 52.6% 54.0% 55.2% 47.5% 57.4% 49.8% 49.7%
IP volume 1,77,181 1,91,167 97,320 1,05,415 51,115 49,674 55,741
OP volume 14,62,439 15,87,997 8,04,886 8,95,356 4,22,499 4,21,367 4,73,989
ARPOB(Rs.) 29,946 31,916 31,406 38,355 31,140 38,458 38,263
ARPP(Rs.) 1,24,187 1,31,232 1,29,575 1,39,884 1,27,959 1,39,398 1,40,316
ALOS 4.15 4.11 4.13 3.65 4.11 3.62 3.67
Total Revenue(Rs.in Mn) 22,235 25,112 12,645 14,753 6,554 6,930 7,823
EBITDA*(Rs.in Mn) 6,299 6,535 3,403 4,071 1,802 1,840 2,231
EBITDA % to Total Revenue 28.3% 26.0% 26.9% 27.6% 27.5% 26.6% 28.5%
PBT (Rs. in Mn) 4,701 4,599 2,572 2,894 1,386 1,272 1,623
PAT (Rs. in Mn) 3,510 3,363 1,880 2,161 1,013 953 1,208

*PBT and PAT are excluding items of:

1) Associates share of profit of Rs. 95.1 Mn in FY22
** PBT & PAT are excluding one time items of - fair value gain on acquisition of control of Rs 148.3 Mn in FY23 Q2 & Rs. 0.22mn Share of loss of associate for Q2 FY24
22
Private & Confidential
 Group Financial Performance
(Rupees in Millions)

TOTAL REVENUE EBITDA

12.9% 12.9% 3.7% 21.2%
16.7% 19.6% 2,231
25,112 14,753 7,823 6,535 4,071 1,840
22,235 6,930 6,299 1,801
12,645 6,554 3,403
16,711 5,361

FY22 FY23 FY24 H1 FY24 H1 FY25 Q2 FY24 Q1 FY25 Q2 FY25 FY22 FY23 FY24 H1 FY24 H1 FY25 Q2 FY24 Q1 FY25 Q2 FY25

PBT* PAT* (4.2%)

(2.2%) 12.5% 27.6% 15.0% 26.8%
4,701 2,894 1,623 3,510 2,161 1,208
1,386 3,363 1,013
4,599 2,572 1,272 3,343 1,880 953
4,473

FY22 FY23 FY24 H1 FY24 H1 FY25 Q2 FY24 Q1 FY25 Q2 FY25 FY22 FY23 FY24 H1 FY24 H1 FY25 Q2 FY24 Q1 FY25 Q2 FY25

*PBT and PAT are excluding items of:

1) Associates share of profit of Rs. 95.1 Mn in FY22
2) ** PBT & PAT are excluding one time items of - fair value gain on acquisition of control of Rs 148.3 Mn in FY23 Q2 & Rs. 0.22mn Share of loss of associate for Q2 FY24
23
Private & Confidential
 Operational and Financial Performance - 1/2
KIMS
Telegana (KIMS) Andhra Pradesh (KIMS)
Particulars
FY23 FY24 H1 FY24 H1 FY25 Q2 FY24 Q1 FY25 Q2 FY25 FY23 FY24 H1 FY24 H1 FY25 Q2 FY24 Q1 FY25 Q2 FY25

Bed Capacity* 1,200 1,200 1,200 1,200 1,200 1,200 1,200 1879 1,914 1,914 2,214 1914 1,914 2,214

Operational Beds 1,085 1,085 1,085 1,085 1,085 1,085 1,085 1606 1,641 1,641 1,841 1641 1,641 1,841

Census Beds 906 906 906 906 906 906 906 1441 1,470 1,470 1,670 1470 1,470 1,670

Non Census Beds 179 179 179 179 179 179 179 165 171 171 171 171 171 171

Occupied Beds 644 647 656 603 667 575 630 1,107 1,154 1,196 1,158 1,238 1,008 1,204

Occupancy 53.7% 54.0% 54.6% 50.2% 55.6% 47.9% 52.5% 58.9% 60.3% 62.5% 52.3% 64.7% 52.6% 54.4%

IP volume 59,077 60,737 31,109 32,413 16,038 15,671 16,742 88,092 93,572 47,659 50,301 24,939 23,494 26,807

OP volume 5,60,936 5,88,869 2,94,896 3,27,703 1,52,626 1,57,166 1,70,537 6,30,178 6,70,011 3,35,411 3,65,956 1,76,315 1,70,163 1,95,793

ARPOB(Rs.) 46,601 50,195 49,711 61,458 50,268 61,345 61,561 14,687 15,996 15,614 19,909 15,491 19,774 20,028

ARPP(Rs.) 1,85,540 1,95,831 1,91,713 2,09,180 1,92,449 2,04,923 2,13,164 67,339 72,198 71,734 77,597 70,741 77,181 77,962

ALOS 3.98 3.90 3.86 3.40 3.83 3.34 3.46 4.58 4.51 4.59 3.90 4.57 3.90 3.89

Total Revenue(Rs.in Mn) 11,096 11,883 5,984 6,928 3,092 3,204 3,724 5,952 6,775 3,426 3,911 1,768 1,818 2,093

EBITDA (Rs.in Mn) 3,710 3,624 1,904 2,144 979 956 1,188 1,445 1,506 819 972 442 435 537

EBITDA % to Total Revenue 33.4% 30.5% 31.8% 30.9% 31.7% 29.8% 31.9% 24.3% 22.2% 23.9% 24.9% 25.0% 23.9% 25.7%

1) Intercompany eliminations and dormant units are adjusted in Telangana

2) Telangana - Secunderad and Kondapur
3) AP Assets - Nellore, Rajahmundry, Srikakulam, Ongole, Visakhapatnam, Anantapur and Kurnool
4) *QNRI Vizag 300 beds added into AP KIMS
24
Private & Confidential
 Operational and Financial Performance - 2/2
Sunshine, Nagpur & Group

Sunshine Nagpur Group

Particulars
FY23 FY24 H1 FY24 H1 FY25 Q2 FY24 Q1 FY25 Q2 FY25 FY23** FY24 H1 FY24 H1 FY25 Q2 FY24 Q1 FY25 Q2 FY25 FY23 FY24 H1 FY24 H1 FY25 Q2 FY24 Q1 FY25 Q2 FY25
Bed Capacity* 527 527 527 527 527 527 527 334 334 334 334 334 334 334 3,940 3,975 3,975 4,610 3,975 3,975 4,610

Operational Beds 527 527 527 527 527 527 527 250 250 250 250 250 250 250 3,468 3,503 3,503 4,038 3,503 3,503 4,038

Census Beds 418 418 418 418 418 418 418 195 195 195 195 195 195 195 2,960 2,989 2,989 3,524 2,989 2,989 3,524

Non Census Beds 109 109 109 109 109 109 109 55 55 55 55 55 55 55 508 514 514 514 514 514 514

Occupied Beds 182 201 202 242 221 222 261 137 145 140 185 157 174 196 2,071 2,148 2,194 2,188 2,283 1,979 2,292

Occupancy 34.6% 38.2% 38.4% 45.9% 41.9% 42.1% 49.5% 41.1% 43.4% 41.8% 55.4% 47.0% 52.0% 58.8% 52.6% 54.0% 55.2% 47.5% 57.4% 49.8% 49.7%

IP volume 20,788 22,094 11,258 14,157 6,066 6,467 7,690 9,224 14,764 7,294 8,544 4,072 4,042 4,502 1,77,181 1,91,167 97,320 1,05,415 51,115 49,674 55,741

OP volume 2,05,697 2,17,051 1,07,126 1,29,088 57,043 59,538 69,550 65,628 1,31,632 67,453 72,516 36,515 34,500 38,016 14,62,439 16,07,563 8,04,886 8,95,356 4,22,499 4,21,367 4,73,989

ARPOB (Rs.) 63,844 63,064 64,294 66,631 60,765 68,325 65,205 29,597 33,782 33,108 32,941 31,535 32,868 33,005 29,946 31,916 31,406 38,355 31,140 38,458 38,263

ARPP(Rs.) 2,04,371 2,10,158 2,11,525 2,08,148 2,03,576 2,13,501 2,03,646 93,448 1,21,517 1,16,005 1,30,548 1,11,745 1,28,430 1,32,449 1,24,187 1,31,232 1,29,575 1,39,884 1,27,959 1,39,398 1,40,316

ALOS 3.20 3.33 3.29 3.12 3.35 3.12 3.12 3.16 3.60 3.50 3.96 3.54 3.91 4.01 4.15 4.11 4.13 3.65 4.11 3.62 3.67

Total Revenue (Rs.in Mn) 4,304 4,658 2,388 2,958 1,240 1,385 1,573 884 1,796 847 1,120 455 522 598 22,236 25,112 12,645 14,753 6,554 6,930 7,823

EBITDA (Rs.in Mn) 1,078 1,155 596 844 323 359 485 66 251 84 189 57 91 99 6,299 6,535 3,403 4,071 1,802 1,840 2,231
EBITDA % to
25.0% 24.8% 25.0% 28.5% 26.1% 25.9% 30.8% 7.5% 13.9% 9.9% 16.9% 12.5% 17.3% 16.5% 28.3% 26.0% 26.9% 27.6% 27.5% 26.6% 28.5%
Total Revenue

1) Sunshine - Paradise, Gachibowli, Karimnagar (Sold in November 22)

2) **Nagpur - Started operations from September 2022. In Q2 FY25 one time cost of 6.32 crs got added resulting in low EBITDA Margin (CMEs & others cost 1.32 crs, loss on sale of machinery 2 crs, R&M of 2.05 crs, other cost 0.95 crs)
3) *QNRI Vizag 300 beds and Nashik 325 beds, Meda Institute 10 beds added into Group
25
Private & Confidential
 Speciality Mix

Others Cardiac Science

22% 16%

Renal Sciences
9%
Mother & Child
10%
Group
H1FY25
Organ Oncology
Transplant 6%
3%

Gastric
Sciences
9%
Neuro Sciences
11%

Orthopaedics
14%

26
Private & Confidential
 Payor & Cluster Profile

PAYOR MIX CLUSTER TOTAL REVENUE

Maharashtra
8%
Andhra Pradesh
Aarogyasri
26%
6%

Cash Telangana
Corporate Group 66%
13% 53%
H1FY25

Group
H1FY25 CLUSTER EBITDA
Maharashtra
Insurance 5%
28% Andhra Pradesh
23%

Group Telangana
72%
H1FY25

1) Telengana - Secunderad , Kondapur, Begumpet & Gachibowli

2) Andhra Pradesh - Nellore, Rajahmundry, Srikakulam, Ongole, Visakhapatnam, Anantapur and Kurnool
3) Maharashtra - Nagpur, Nashik
27
Private & Confidential
 Key Achievements in Q2 FY25

28
Private & Confidential
 Key Achievements in Q2 FY25

29
Private & Confidential
 Key to our success

Doctor Affordable
Partnerships Quality Care

Modern
Medical Infra

30
Private & Confidential
 Expansion plans

Current Incremental Approx. Expected Year of

Units New Departments
Beds Beds Capex Operation
Bangalore (Project-1) - 415 All Specialities 350-400 Cr Q4 FY25
Bangalore (Project-2) - 250 All Specialities 180-200 Cr Q4 FY25
Mumbai (Thane) - 300 All Specialities 500-525 Cr Q4 FY25
Srikakulam 200 120 All Specialities 70-75 Cr Q4 FY25
Ongole 350 50 Cancer Centre 40-50 Cr Q4 FY25
Anantapur 250 250 Cancer Centre / Mother & Child 90-110 Cr Q4 FY26
Kondapur 200 500 All Specialities 300-350 Cr Q1 FY27

O&M / Leased Asset Plans

Current Incremental Expected Year of
Units New Departments Commercials
Beds Beds Operation
Kannur (Leased)1 - 200 All Specialities 5% of Rev Q3 FY25
Guntur (O&M)2 - 200 All Specialities 5% of Rev Q3 FY25

1) 5% of the revenue to be paid by KIMS to the lessor

2) 5% of the revenue to be received by KIMS for management of the hospital
31
Private & Confidential
 KIMS Sreechand Hospital, Kannur

About Kannur:
Kannur is one of the 14 districts along the west coast in the state of Kerala, India. The city of Kannur is the
district headquarters and gives the district its name.
Kannur is the sixth-most urbanized district in Kerala, with more than 50% of its residents living in urban
areas. Kannur has an urban population of 1,640,986, which is the second largest in Kerala after Ernakulam
District.
In Kannur have one International Airport. Airport has an integrated passenger terminal for both international
and domestic travellers with a floor area of 97,000 m2 (10,40,000 sq ft) for arrival and departure separately.
It is able to handle up to 2,000 passengers during peak hours with its unique swing facility.
Competitive Landscape:
• Aster MIMS Kannur • BMH Gim Care Hospital • AKG Hospital • Thalasery Co-operative Hospital
• Indiragandhi Hospital Thalassery • Dhanalakshmi Hospital • Koyili Hospital
About the Hospital:
Sreechand Speciality Hospital hospital situated in Kannur town, Kerala. It started operations in the year
2020 Hospital is currently functioning with 200 beds. Currently, the hospital has 235 Cents of land with an
existing floor area of 1.12 lacs sqft. and built-up area of 1.42 lacs sqft.
• 170 Census Beds • 30 Non Census beds) • 6 OTs • 1 CathLab

Operational Parameters:
ARPOB - 21,000
Key Existing Specialities - Cardiology, Plastic Surgery, Orthopedics
Proposed Specialities to be added - Internal Medicine, Neuro Surgery, Neurology, Nephrology,
Urology, Medical & Surgical Gastroenterology, General Surgery, Gynaec & Pediatrics

32
Private & Confidential
 KIMS-Manavata, Nashik

About Nashik:
Nashik is a city in the northern region of the Indian state of Maharashtra. Situated on the banks of the
river Godavari. The population of Nashik city is around 2.2 million and is emerging as one of the fastest-
growing cities in India. Nashik is located about 165 km (103 mi) northeast of the state capital Mumbai,
and about 210 km (130 mi) north of Pune. The Mumbai-Pune-Nashik region is called the "Golden Triangle
of Maharashtra". With its high agricultural production, Nashik is dubbed the Napa Valley of India and the
"Wine Capital of India" as more than half of India's vineyards and wineries are located here.
Competitive Landscape:
• Apollo Hospital • Medicover Hospital • Sahyadri Super Speciality Hospital
About the Hospital:
KIMS Manavata Multi-speciality Hospital is a 325 bedded Hospital that offers services spread across 30
specialities with some of the finest medical experts, forming a part of a distinguished medical team.
It brings in some of the most modern treatment techniques and state-of-the-art medical infrastructure to
deliver comprehensive and seamless healthcare service.

Highlights:
• 325 beds • 70 Advanced Critical Care beds • 65+ OPD & dedicated health check up unit
• 9 OT • 1 CT • 1 MRI • 3 Endoscopy suits with Dedicated ERCP • 2 CathLab • Dialysis Units
• Comprehensive Mother and Child Care • 2 Labour Rooms • Speciality Care for High-risk Pregnancies
• Level 4 NICU for Premature Babies • Advanced PICU

Operational Parameters:
ARPOB - 33,000
Key Existing Specialities - Cardiology, Cardiothoracic Surgery, Plastic Surgery, Orthopedics,
Internal Medicine, Neuro Surgery, Neurology, Nephrology, Urology, Medical & Surgical Gastroenterology,
General Surgery, Gynaec & Pediatrics

33
Private & Confidential
 KIMS Sikhara, Guntur

Introduction:
Guntur, a prominent city situated on the Eastern Coastal Plains of India, lies
approximately 30 kilometres south of Amaravati, the bustling capital of Andhra Pradesh.
Spanning an area of 159.46 square kilometres, Guntur is home to a diverse population
of about 743,354 residents, with Telugu being the predominant language spoken
throughout the city.
Competitive Landscape:
• Aster Ramesh Hospitals • Lalitha Super Specialty Hospital • AIIMS, Mangalgiri
• Manipal Hospital, Vijayawada, Omega Hospital

About SIKHARA Hospital

SIKHARA Hospital is situated in Guntur city, yet to start the operations it has a capacity
of 200 beds with (174 Census Beds and 26 Non-Census beds),
8 OTs and 1 Cath Lab.
The hospital has 1 acre land with an existing built-up area of 1.05 lac sq. ft. and further
additional 20,000 sq plus there is additional plot of 1 acre land adjacent to the hospital
for potential lease.
The hospital has potential to achieve an ARPOB of 35K. The current team has an
excellent Surgical Gastro, Neuro surgery, Orthopedics, Critical Care, Internal Medicine
Team and Cardiology. We will be adding Cardiothoracic Surgery, Plastic Surgery, Internal
Medicine, Neurology, Nephrology, Urology, Medical Gastroenterology, General Surgery,
Gynaec & Pediatrics

34
Private & Confidential
 Profit and Loss Statement
(Rupees in Millions)

Consolidated

Particulars Q2 FY25 Q1 FY25 Q2 FY24 QoQ(%) YoY(%) H1 FY25 H1 FY24 YoY(%)

Operating Revenue 7,773 6,884 6,525 12.9% 19.1% 14,657 12,585 16.5%

Other Income 50 46 29 8.4% 73.3% 96 60 60.1%

Total Revenue 7,823 6,930 6,554 12.9% 19.4% 14,753 12,645 16.7%

EBITDA 2,231 1,839 1,802 21.3% 23.8% 4,070 3,403 19.6%

EBITDA (%) on operating revenue 28.7% 26.7% 27.6% 27.8% 27.0%

PBT* 1,622 1,271 1,387 27.6% 16.9% 2,893 2,572 12.5%

PBT (%) on total revenue 20.7% 18.3% 21.2% 19.6% 20.3%

PAT* 1,207 952 1,013 26.8% 19.2% 2,159 1,879 14.9%

PAT (%) on total revenue 15.4% 13.7% 15.5% 14.6% 14.9%

Basic EPS (Rs.)* 2.68 2.16 2.30 24.0% 16.7% 4.85 4.32 12.2%

Diluted EPS (Rs.) 2.68 2.16 2.30 24.0% 16.7% 4.85 4.32 12.2%

IND AS 116 34 74 51 109 74

EBITDA Post IND AS & Other Income 2,315 1,960 1,882 18.1% 23.0% 4,275 3,537 20.9%

1) *EBITDA - Pre IND AS & Excl. Other Income

2) PBT & PAT are excluding one time items of - Share of loss of associate of Rs.0.22 mn in Q2 FY24
3) Minority share of EBITDA for Q2FY25 stands at 13.6%
4) *The equity shares of the Companyof Rs.10/ has been sub-divided into 5 equity shares of Rs.2/- each w.e.f. September 13,2024, accordingly EPS has been restated for all the periods.
35
Private & Confidential
 Corporate Structure (As on 30 th
September'24)

Krishna Institute of Medical Sciences Limited

KIMS Secunderabad KIMS Nellore KIMS Rajahmundry KIMS Ongole KIMS Hospitals KIMS QNRI KIMS Swastha
(100%) (100%) (100%) (100%) Bengaluru Visakhapatnam Kerala
(100%) (100.0%) (100.0%)

Doctor Partnership Hospitals

AHPL KHEPL KIMS ICON KIMS Saveera KIMS KIMS Sunshine KIMS-Manavata SPANV MIPPL*
Srikakulam Kondapur Visakhapatnam Anantapur Kurnool Begumpet Nashik Nagpur Hyderabad
(67.7%) (90.7%) (51.0%) (76.5%) (55.0%) (65.8%) (51.0%) (69.3%) (51.0%)

KIMS Gachibowli
(100.0%)

*Meda Institute of Podiatry Private Limited

36
Private & Confidential
 Thank You

37
Private & Confidential